5-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine
≥95%
- Product Code: 48856
CAS:
1190317-11-3
Molecular Weight: | 212.05 g./mol | Molecular Formula: | C₇H₆BrN₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD12962871 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, away from light, stored in an inert gas |
Product Description:
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting kinase enzymes. Its structure is often incorporated into drug candidates designed for the treatment of cancers, inflammatory diseases, and other conditions regulated by kinase activity. Additionally, it is used in the development of small molecule inhibitors that can modulate specific signaling pathways in cells. Researchers also explore its potential in creating novel therapeutic agents due to its unique heterocyclic framework, which can enhance binding affinity and selectivity in drug-target interactions.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | Ft47,222.92 |
+
-
|
0.250 | 10-20 days | Ft82,615.86 |
+
-
|
1.000 | 10-20 days | Ft206,539.65 |
+
-
|
5-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting kinase enzymes. Its structure is often incorporated into drug candidates designed for the treatment of cancers, inflammatory diseases, and other conditions regulated by kinase activity. Additionally, it is used in the development of small molecule inhibitors that can modulate specific signaling pathways in cells. Researchers also explore its potential in creating novel therapeutic agents due to its unique heterocyclic framework, which can enhance binding affinity and selectivity in drug-target interactions.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :